NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
Taiwan Semiconductor
TSM
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
MNMD Mind Medicine
- 6.2300
- +0.1600+2.64%
Close Mar 4 16:00 ET
- 6.3000
- +0.0700+1.12%
Post 20:01 ET
456.86MMarket Cap-3.64P/E (TTM)
6.2650High5.7900Low2.32MVolume6.0100Open6.0700Pre Close13.91MTurnover3.40%Turnover RatioLossP/E (Static)73.33MShares12.220052wk High1.74P/B425.19MFloat Cap5.032952wk Low--Dividend TTM68.25MShs Float86.5500Historical High--Div YieldTTM7.83%Amplitude2.1200Historical Low6.0010Avg Price1Lot Size
Mind Medicine News
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
Mind Medicine Analyst Ratings
Optimistic Buy Rating for Mind Medicine's MM120 Amid Promising Phase 3 Progress and Strong Phase 2b Results
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
Evercore Initiates Mind Medicine(MNMD.US) With Buy Rating, Announces Target Price $23
Mind Medicine Analyst Ratings
Evercore ISI Group Initiates Coverage On Mind Medicine With Outperform Rating, Announces Price Target of $23
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital
Mind Medicine Analyst Ratings
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
Mind Medicine (MNMD) Receives a Buy From Oppenheimer
RBC Capital Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $21
RBC Capital Remains a Buy on Mind Medicine (MNMD)
Mind Medicine Analyst Ratings
Maxim Group Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $18
Oppenheimer Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $20
H.C. Wainwright Maintains Mind Medicine(MNMD.US) With Buy Rating, Maintains Target Price $55
Mind Medicine's Strategic Advancements and Clinical Progress Drive Buy Rating
CCORF Maintains Mind Medicine(MNMD.US) With Buy Rating, Raises Target Price to $16